Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement
29. November 2018 23:46 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces the release of the Company’s Condensed...
Lexington Announces Non-Brokered Private Placement
27. August 2018 09:00 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...
Lexington Announces First Multicenter Clinical Study Site
21. August 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Biosciences Announces Results of Annual General Meeting
02. Juli 2018 19:32 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes...
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
11. Juni 2018 07:45 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11,...
Lexington Announces Brokered Private Placement
04. Mai 2018 07:00 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
Lexington Receives Approval to Commence Clinical Study
24. Januar 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Completes IRB Submission in Preparation for Clinical Study
18. Januar 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) --
Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
Lexington Biosciences Announces Exercise of Warrants
11. Januar 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...